Evidence map›Paper›PMID 27174477›Full record

ArticleAmerican journal of respiratory and critical care medicine2016

The Airway in Idiopathic Pulmonary Fibrosis: Protecting the Lung or Promoting Disease?

Changwan Ryu, Robert J Homer, Erica L Herzog

Abstract readComment
In one paragraph

Article in American journal of respiratory and critical care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Ciliated (FOXJ1Cells · 2022
    Article
  6. Article
  7. Update in Interstitial Lung Disease 2019.American journal of respiratory and critical care medicine · 2020
    Review
  8. Article
  9. Review
  10. Article
  11. Update in Interstitial Lung Disease 2016.American journal of respiratory and critical care medicine · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Changwan Ryu1 Department of Internal Medicine Yale University School of Medicine New Haven, Connecticut and.ORCID 0000-0001-6211-4327
Robert J Homer2 Department of Pathology Yale University School of Medicine New Haven, Connecticut.ORCID 0000-0002-2055-5885
Erica L Herzog1 Department of Internal Medicine Yale University School of Medicine New Haven, Connecticut and.

Funding

Training Translational Lung Biology and PathobiologyT32HL007778 · NHLBI · YALE UNIVERSITY · PI Erica L Herzog, NAFTALI KAMINSKI · 1994 to 2026
$14.4M
Novel Immunologic Effects of Semaphorin 7a in IPFR01HL109233 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2011 to 2019
$3.7M
Neuroimmune Molecules in Scleroderma Lung FibrosisR01HL125850 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2016 to 2019
$1.7M
Significance Circulating Semaphorin 7a+ve Cells in Pulmonary SarcoidosisU01HL112702 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2012 to 2014
$488k
NHLBI NIH HHS R01 HL109233NHLBI NIH HHS R01 HL125850NHLBI NIH HHS T32 HL007778NHLBI NIH HHS U01 HL112702
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Idiopathic Pulmonary FibrosisLungHumansPulmonary Fibrosis

Identifiers

PMID27174477
PMCPMC4872674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.